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ABSTRACT
Human, rat, and mouse studies have demonstrated the existence of a population of adipose-derived adult
stem (ADAS) cells that can undergo multilineage differentiation in vitro. However, it remains unclear
whether these cells maintain their multilineage potential in vivo. The aim of this study was to examine the
in vitro and in vivo characteristics and behavior of a potential population of murine ADAS (muADAS)
cells isolated from the visceral fat of the abdominal cavity of C57BL/10J mice. We used flow cytometry to
examine the cells’ expression of CD29, CD31, CD45, CD34, CD44, CD144, CD146, Flk1, and Sca-1. The
isolated cell population was CD45 negative, which precludes contamination by hematopoietic cells, but
was partially positive for Sca-1 and CD34: 2 stem-cell markers. After induction in conditioned medium,
the muADAS cells gained the ability to undergo adipogenic, osteogenic, chondrogenic, myogenic, and
hematopoietic differentiation in vitro. The muADAS cells readily differentiated to form bone and car-
tilage in vivo for up to 24 weeks, but their ability to regenerate muscle or reconstitute bone marrow was
found to be limited.
INTRODUCTION
RESEARCHERS TRADITIONALLY HAVE BELIEVED that stemcells in adult tissues can generate only the types of cells
present within the tissues in which the stem cells reside;
however, increasing numbers of papers have reported the
detection of pluripotent stem and progenitor cells in various
types of adult tissues, including bone marrow, muscle, brain,
skin, and adipose tissue.1–6 These cells, which purportedly
can differentiate toward various lineages both in vitro and in
vivo, could serve as the basis for a wide variety of tissue
regeneration and repair applications. Unfortunately, the iso-
lation of pluripotent stem cells from most of the tissue
sources investigated has practical limitations. Often, the
source tissue is not abundant, or cell harvesting relies on an
invasive technique (e.g., bone marrow isolation) or is clini-
cally impossible (e.g., brain tissue isolation). Ideal stem cell
sources would be easily accessible and available in unlimited
amounts. Because adipose tissue fits these criteria, it is an
attractive candidate as a stem cell source. Scientists recently
have demonstrated that certain cells isolated from sub-
cutaneous or visceral fat tissue can differentiate into a vari-
ety of cell types in vitro, including adipocytes, osteoblasts,
chondrocytes, and myoblasts.6–8 These cells have been
termed ‘‘adipose-derived adult stem (ADAS) cells’’ because
they are self-renewing and can be induced to differentiate
toward various mesodermal lineages.9,10
Adipose tissue, which is abundant, expendable, and easy to
obtain from the body, is derived from the mesoderm and
contains 2 different cell populations: mature adipose cells
and stroma vascular fraction (SVF) cells.11 SVF cells isolated
from rat adipose tissue have exhibited multipotent differ-
entiation in vitro.10,12 The aim of our study was to deter-
mine whether visceral adipose tissue from mice contains
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a population of adipose-derived mesodermal stem cells that
can undergo multilineage differentiation in vitro and in vivo.
The existence of such stem cells would validate the notion
that these cells reside in adipose tissue and can be used to
improve the healing of various types of tissues.
MATERIALS AND METHODS
Animals
The normal mice (C57BL/10J and BALB/cJ), mdx mice
(C57BL/10ScSn DMDmdx/J), SJL/J mice, and SCID mice
used in this study were purchased from The Jackson La-
boratory (Bar Harbor, ME). The Children’s Hospital of
Pittsburgh’s Institutional Animal Care and Use Committee
approved all animal protocols used for these experiments.
Cell harvest and culture
For isolation of murine adipose-derived adult stem
(muADAS) cells, visceral adipose tissue was excised sepa-
rately from six C57BL/10J mice and five BALB/cJ mice
(4–8 weeks of age), finely minced, and digested using
0.075% collagenase type XI (Sigma, St. Louis, MO) for
45 min at 378C. Enzyme activity was neutralized by treat-
ment with Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% fetal bovine serum (FBS). The cell sus-
pension was centrifuged at 1200g for 10 min to separate the
floating adipocytes from the SVF. The SVF was resuspended
in ammonium chloride (160 mM), incubated at room tem-
perature for 10 min to lyse contaminating red blood cells,
and then centrifuged as described above. After filtration of
the cell suspension through a 100-mm nylon strainer to re-
move cellular debris, cell number and viability were de-
termined using trypan blue exclusion. The SVF cells were
plated in T75 flasks overnight in control medium (DMEM,
10% FBS, 1% penicillin/streptomycin) at 378C in 5% carbon
dioxide (CO2). After incubation for 24 h, the flasks were
washed extensively uisng phosphate buffered solution (PBS)
to remove residual nonadherent cells. The adherent muA-
DAS cells were expanded using serial passaging.
Characterization of muADAS cells
Flow cytometry was used to characterize muADAS cells
obtained from C57BL/10J and BALB/cJ mice and grown for 4
passages and 10 passages under control conditions. Cultured
cells were trypinized, spun, and washed in cold PBS 1X
(Mediatech, Herndon, VA) containing 2% FBS. The cells then
were divided into aliquots and were spun to form a pellet. Cells
were blocked using mouse serum (Sigma) diluted 1:10 in PBS
and rat anti-mouse CD16/CD32 (BD PharMingen, San Diego,
CA) for 10 min on ice. The primary antibodies (applied in
optimal amounts) included a biotin-conjugated rat anti-mouse
monoclonal antibody against CD34 and CD29 (surface pro-
teins used to define mesenchymal stem cells and progenitor
cells) followed by streptavidin-APC, PE-conjugated mouse
anti-Sca-1, and FITC-conjugated mouse anti-CD45 and
anti-CD44 (all from BD PharMingen, San Diego, CA). To
exclude dead cells, 7-aminoactinomycin D (Via-Probe, BD
PharMingen) was added to each tube. Live cells were analyzed
using a FACSCalibur flow cytometer (Becton Dickinson, San
Jose, CA) and CellQuest software (Becton Dickinson). Ana-
lysis of surface protein expression was performed using ap-
propriate gating on viable CD45-negative cells to eliminate
contaminating hematopoietic cells. The isotype antibody
control samples obtained for each individual cell population
were used to set the dot-plot intercepts used for the analysis.
In vitro adipogenic differentiation assay
A previously described method was used to analyze adi-
pogenesis.6 Trypsin/ethylenediaminetetraacetic acid was
used to harvest the muADAS cells, which then were replated
in 6-well plates (100,000 cells per well) in control medium to
allow attachment. Twenty-four h later, the medium was re-
placed with new control medium or adipose medium (con-
trol medium plus insulin [10 mM], dexamethasone [1mM],
isobutyl-methylxanthine [0.5 mM], and indomethacin [200
mM] [all from Sigma-Aldrich]). Cultures were maintained
for 14 days, and medium was changed every 2 days. The
cultures then were assessed using Oil Red O stain, which
serves as an indicator of intracellular lipid accumulation.
The cells were fixed for 10 min at room temperature in 10%
neutral buffered formalin and were washed with distilled
water. They then were incubated in Oil Red O reagent for
30 min and washed 3 times with distilled water. The cells
were counterstained with hematoxylin for 1 min.
In vitro chondrogenic differentiation assay
Pellet culturing was performed as described previ-
ously.13–15 Cells (n ¼ 250,000) were placed in a 15-mL
conical polypropylene tube and were centrifuged at 600g
for 5 min; they then were left on the bottom of the tube
and cultured in control medium or defined medium: high-
glucose DMEM supplemented with 1% ITSþPremix (BD
Biosciences, Bedford, MA), L-ascorbic acid-2-phosphate
(0.1 mM, Wako Pure Chemical Industries, Ltd. Osaka,
Japan), dexamethasone (1107 M, Sigma), proline (400 mg/
mL, Sigma), and bone morphogenetic protein 4 (BMP4)
(500 ng/mL, R&D Systems). After the addition of 1 mL of
chondrogenic medium to each tube, the pelleted cells were
incubated at 378C in 5% CO2. The medium was changed
every 2 to 3 days. Pellets were harvested at different time
points (Days 7, 14, 21) and were embedded in paraffin as
detailed in the standard protocol (available on the Cambrex
Company website). Chondrogenesis was confirmed by use
of the histologic stain Alcian blue at a low pH to stain
the highly sulfated proteoglycans that are characteristic of
cartilaginous matrix. After that, sections were counter-
stained with nuclear fast red, which specifically stains cell
nuclei.
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In vitro osteogenic differentiation assay
The in vitro osteogenic assay was performed as de-
scribed previously.6 Osteogenic differentiation was in-
duced by culturing muADAS cells in osteogenic medium
(OM, control medium supplemented with dexamethasone
[0.1 mM], ascorbate-2-phosphate [50 mM], and b-glycer-
ophosphate [10 mM] [all from Sigma]). The medium was
changed every 3 days. Osteogenesis was assessed using von
Kossa staining and observation of alkaline phosphatase
(ALP) activity 2 and 4 weeks after initial osteogenic in-
duction, as described previously.16 The cells were incubated
in OM for 2 weeks and rinsed with PBS. The commercially
available Sigma AP kit 86-c (Sigma) then was used to detect
ALP activity. The cells used for von Kossa staining were
incubated in OM for 4 weeks and fixed at room temperature
with 4% paraformaldehyde for 1 h. They were rinsed with
distilled water and then were incubated for 30 min in 1%
silver nitrate solution in the dark. The cells then were rinsed
again with distilled water and exposed to ultraviolet light for
60 min. Secreted calcified extracellular matrix appeared as
black nodules after von Kossa staining.
In vivo chondrogenic and osteogenic
differentiation assays
muADAS cells were seeded at a density of 1.5 106 cells
in 75-cm2 flasks and were grown to 50% confluence. On the
day of transduction, cells were washed twice with sterile
PBS and were incubated for 16 h with a mixture of 2 mL of
retro-LacZ viral suspension (1 106–5 106 cfu/mL),
18 mL of DMEM supplemented with 10% FBS, and poly-
brene (8 mg/mL) in 5% CO2 at 378C. This same solution was
replaced every 16 h for 32 h. The percentage of LacZ-posi-
tive transduced cells (muADAS-LacZ cells) was determined
using X-galactosidase (gal) staining. The aforementioned
technique also was used to transduce muADAS-LacZ cells
with a retro-BMP4 virus. Medium containing 10 mL of
retro-BMP4 viral suspension (5 105 cfu/mL), 10 mL of
DMEM with 10% FBS, and polybrene (8 mg/mL) was added
to the flasks. muADAS-LacZ cells were cultured in this
medium for 48 h, with medium changes performed every
16 h. After transduction, the muADAS-LacZ-BMP4 cells
were cultured in 6-well plates until the cultures reached
confluence. The culture medium was collected after 48 h,
centrifuged at 2000 rpm and 4oC for 5 min to remove cellular
debris, and then used to perform a BMP4 bioassay. A pre-
viously described BMP4 assay was used to determine the
level of functional BMP4 secreted by the transduced cells.17
After detection of bioactive BMP4 in the culture medium
(100  22 ng/million cells/24 h) of muADAS-LacZ-BMP4
cells, 3 105 cells in a 100-mL cell suspension were seeded
on the surface of a 6 mm 6 mm piece of sterile collagen
sponge (Gelfoam, Pharmacia & Upjohn Co., Ann Arbor,
MI). After the Gelfoam absorbed all the cell suspension,
3 mL of DMEM supplemented with 10% FBS was added to
each well; the wells then were placed in a cell incubator
overnight.
Animal surgery was performed on the following day.
Samples were implanted into the skeletal muscle pouch of
the gluteofemoral muscle of each SCID mouse. The mice
were examined radiographically and then killed at different
times (2, 4, 5, and 24 weeks) after cell implantation. The
harvested tissue samples obtained 2, 4, and 5 weeks after
cell implantation were treated with CRYO-GEL Embed-
ding Medium (Cancer Diagnostics, Inc., Birmingham, MI),
rapidly frozen, and stored at –808C. Frozen sections were
fixed in 1% glutaraldehyde for 1 min and then were washed
3 times in PBS. Some of the sections were stained in X-gal
solution and counterstained with eosin. Other sections were
stained in X-gal solution and immunostained with collagen
type II (1:200 dilution, Santa Cruz Biotech, Santa Cruz,
CA) and osteocalcin (1:200 dilution, Santa Cruz Biotech),
as detailed in the manufacturer’s protocol (Vectastain Elite
ABC kit, Vector Laboratories, Burlingame, CA). Some of
the 24-week samples were frozen and sectioned, whereas
others were decalcified and embedded in paraffin. The
frozen sections were stained in X-gal solution and coun-
terstained with eosin. The paraffin-embedded sections were
stained with Alcian blue and eosin. Some sections were
immunostained for collagen type II or osteocalcin in ad-
dition to b-gal (1:200 dilution, Abcam, Inc., Cambridge,
UK).
In vitro and in vivo myogenic
differentiation assays
Myogenic differentiation was induced by culturing
muADAS cells in myogenic medium (MM: control med-
ium supplemented with dexamethasone [0.1 mM, Sigma],
hydrocortisone [50 mM, Sigma], and 5% horse serum) for
4 weeks and was confirmed using desmin staining. The cells
were rinsed twice with PBS, fixed for 1 min with methanol,
and again washed several times with PBS. The cells were
blocked with 5% horse serum at room temperature for 1 h
and then were incubated with the primary antibody rabbit
immunoglobulin G (IgG) anti-desmin (1:250 in PBS, Sig-
ma) overnight at 48C. After being rinsed thoroughly with
PBS, cells were incubated with biotinylated anti-rabbit IgG
antibody (1:250, Sigma) for 1 h at room temperature. The
cells then were rinsed with PBS and incubated for 30 min at
room temperature with streptavidin conjugated Cy3 fluor-
ochrome (1:300, Sigma). Slides were viewed with a Nikon
Diaphot 300 fluorescence microscope (Nikon, Garden City,
NY).
In vivo myogenic differentiation was evaluated by in-
jection of muADAS cells into the skeletal muscle of
mdx mice, which model Duchenne muscular dystrophy.18
muADAS cells from passages 3 to 5 were grown to 60%
confluence in control medium. To enable tracking of cells
after injection into gastrocnemius muscles, muADAS cells
were genetically engineered to express the LacZ reporter
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gene (muADAS-LacZ cells), as described above for the in
vivo chondrogenic and osteogenic assays. The cells were
harvested, mixed with FluoSpheres (Molecular Probes,
Eugene, OR) in 20 mL of Hanks’ balanced salt solution
(HBSS, Invitrogen, Grand Island, NY), and injected
(5 105 cells per injection) into a single site within the
gastrocnemius muscles of 8-week-old mdx mice. Injected
gastrocnemius muscles were harvested on Day 15 and were
stained for LacZ and dystrophin. For LacZ staining, the
sections were fixed in 1% glutaraldehyde, incubated over-
night with X-gal substrate at 378C, and counterstained with
eosin. The sections were mounted in Gel/Mount (M01,
Biomeda, Plovdiv, Bulgaria) and observed with a light
microscope (Nikon Eclipse E800). For dystrophin staining,
slides were fixed with acetone and blocked with 5% horse
serum. The primary antibody was rabbit anti-dystrophin
(1:1000, gift from Dr. T. Partridge). Sections then were
washed in PBS and were incubated with biotinylated anti-
rabbit IgG (1:300, Vector) followed by streptavidin-Cy3
(1:500, Sigma). The dystrophin-positive myofibers were
visualized using fluorescence microscopy.
In vitro and in vivo hematopoietic
differentiation assays
In vitro differentiation of the muADAS cells toward the
hematopoietic lineage was induced by culturing the cells in
methylcellulose as described previously.19 muADAS cells
(n ¼ 1 105) in 1 mL of Methocult GF M3434 culture
media (Stem Cell Technologies, Vancouver, Canada) were
plated in a 35-mm petri dish and cultured in a humidified
5% CO2 atmosphere maintained at 378C. Colonies were
counted 10 days after plating. Colonies from triplicate
cultures were individually lifted from the methylcellulose
culture and were centrifuged to glass slides with a Cytospin
(Shandon Southern, Sewickley, PA). Cells then were
stained using the HEMA 3 Stain Set (Biochemical Science,
Inc., Swedesboro, NJ).
In vivo hematopoietic differentiation of the muADAS
cells was determined by transplantation of muADAS cells
into 8- to 10-week-old SJL/J mice that had been subjected to
a single lethal dose of radiation (10 Gy) 1 day before cell
transplantation. We used this alternative strain of mouse to
distinguish the differentiated donor cells (CD45.2 positive)
from the SJL/J host cells (CD45.2 negative), as described
previously.19 Cells (1 105, 5 105, or 1 106 in 400 mL of
HBSS) were injected intraperitoneally or intravenously into
the tail vein. Mice were given acidified water and autoclaved
food.
RESULTS
Phenotypic characterization of the muADAS cells
The visceral adipose tissue from 1 mouse yielded ap-
proximately 7.0 106 nucleated cells. Within 4 passages
after the initial plating of the primary culture, muADAS
cells appeared as a monolayer of large, flat cells. As the cells
approached confluence, they acquired a spindle-shaped or
fibroblast-like appearance. We used flow cytometry to eval-
uate the expression of CD45, Sca-1, CD34, CD44, and
CD29 cell-surface antigens on the muADAS cells obtained
from C57BL/10J and BALB/cJ mice. The muADAS cells
from both mouse strains were negative for CD45, a he-
matopoietic cell surface marker (Fig. 1A). Approximately
31% and 10% of the muADAS cells were Sca-1 and CD34
positive, respectively (Fig. 1B). muADAS cells were neg-
ative for CD31, CD144, CD146, and flk-1 at the time of
flow cytometry analysis (after 4 passages; data not shown).
Because we observed similar results in cells obtained from
both strains (Fig. 1C), we used only C57BL/10J mice for
the remainder of the study. Flow cytometry analysis re-
vealed that the muADAS cell marker profile changed dur-
ing expansion. After passage 10, the cells showed increased
Sca-1 expression (74.94%) and decreased CD34 expression
(3.25%) (Fig. 1D).
muADAS cells undergo adipogenic
differentiation in vitro
To determine whether muADAS cells undergo adipo-
genesis, we cultured muADAS cells in adipogenic medium.
Oil Red O staining performed 2 weeks later revealed cy-
toplasmic lipid droplets, which are indicative of the adi-
pogenic phenotype. These results indicate that the
muADAS cells cultured in adipogenic medium underwent
adipogenic differentiation (Fig. 2A), whereas muADAS
cells maintained in control medium did not (Fig. 2B).
muADAS cells undergo chondrogenic
differentiation in vitro
In the chondrogenic assay, the seeded muADAS cells
initially formed a flat disk of cells that gradually expanded
into a rounded pellet. After 21 days in culture, sections of
pellet showed early cartilage formation, as indicated by
Alcian blue staining (pH 1), which is specific for cartila-
ginous matrix (Fig. 2C). In contrast, cells cultured in
control medium resulted in only light Alcian blue staining
(Fig. 2D).
muADAS cells undergo osteogenic
differentiation in vitro
muADAS cells cultured in osteogenic medium for 14
days expressed endogenous ALP (Fig. 2E). Moreover,
mineralized nodular structures formed within 4 weeks, as
confirmed by von Kossa staining (Fig. 2G). In contrast,
muADAS cells cultured in control medium showed no
evidence of ALP expression or formation of calcified ex-
tracellular matrix (Fig. 2F, H).
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muADAS cells undergo chondrogenic
and osteogenic differentiation in vivo
We transduced the muADAS cells with a retrovirus con-
taining the LacZ gene, a reporter gene that we used to track
the fate of our donor cells in vivo. The LacZ gene trans-
duction efficiency was 61%. X-gal staining enabled us to
track the muADAS-LacZ cells on the basis of their b-gal
expression (blue nuclei) (Fig. 3A). We then cotransduced
these cells with a retrovirus containing the BMP4 gene.17
The cotransduced muADAS cells secreted 100  22 ng of
BMP4/million cells/24 h. Twenty-eight days after implan-
tation of 3 105 muADAS cells cotransduced with LacZ and
BMP4 into the host mice, bone formation was visible using
radiographic examination (Fig. 3B). Histologic analysis
showed that the muADAS cells differentiated toward
chondrogenic and osteogenic lineages in vivo (Fig. 3 C–F).
Radiographic analysis 24 weeks after cell implantation
showed solid bone formation (Fig. 4A). Histologic results
indicated that cortical-like bone tissue and cartilage formed
in the area of ectopic ossification (Fig. 4B, C). Immuno-
staining of b-gal and collagen type II or osteocalcin supports
the histologic findings that the implanted muADAS cells
continued to survive and participate in the generation of
ectopic bone and cartilage for up to 24 weeks (Fig. 4B–F).
muADAS cells’ ability to undergo myogenic
differentiation in vitro and in vivo
We examined the muADAS cells’ myogenic differ-
entiation in vitro by staining for desmin and in vivo by
staining for dystrophin and evaluating muscle regeneration
after implanting muADAS cells into the skeletal muscle of
mdx mice. muADAS cells cultured for 6 weeks in myo-
genic medium expressed desmin (Fig. 5A). To determine
the in vivo myogenic capacity of muADAS cells, we in-
jected 5 105 muADAS-LacZ cells into the gastrocnemius
muscles of mdx mice. We killed the mice 15 days after
injection and harvested the injected muscles to examine
b-gal and dystrophin expression. Fifteen days after injection,
we detected few LacZ-positive myofibers, which resulted
from the fusion of donor-derived transduced muADAS
cells with host myofibers (Fig. 5B, arrow). We also detected
few dystrophin-positive myofibers in the injected muscle
(data not shown). Our findings suggest that muADAS
cells undergo limited myogenic differentiation in vitro and
in vivo.
In vitro and in vivo hematopoietic
differentiation by muADAS cells
To evaluate the hematopoietic differentiation of muA-
DAS cells in vitro, we plated them in semisolid methylcel-
lulose medium supplemented with cytokines known to
promote myeloid differentiation. Of the 6 populations of
muADAS cells examined, 1 formed typical hematopoietic
colonies after 10 days in culture (Fig. 5C). HEMA 3 Stain
Set staining also revealed granulomonocytic colonies
(Fig. 5D).
We also injected 4 populations of muADAS cells
intravenously (tail vein) or intraperitoneally into lethally
FIG. 1. (A) Flow cytometric analysis of CD45, (B) Sca-1, and CD34 expression on murine adipose-derived adult stem (muADAS)
cells at passage 4. muADAS cells were CD45 negative, but 31% of them were Sca-1 positive and 10% were CD34 positive. (C) The
marker profiles of muADAS cells from both C57BL/10J and BALB/cJ mice were similar. (D) CD34 expression was lower whereas
Sca-1 expression was higher on C57BL/10J cells at passage 10.
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FIG. 2. Murine adipose-derived adult stem (muADAS) cells accumulated lipid-filled droplets when cultured for 2 weeks in adipogenic
medium. (A) Oil Red O staining revealed lipid-filled intracellular vacuoles (magnification 40). (B) muADAS cells maintained in
control medium remained negative for Oil Red O staining (magnification 40). (C) We observed positive Alcian blue staining, which
indicates the presence of sulfated proteoglycans, in the cells cultured 3 weeks in chondrogenic medium (magnification 60).
(D) muADAS cells maintained in control medium were only slightly positive after Alcian blue staining (magnification 60).
(E) muADAS cells grown in osteogenic medium exhibited ALP activity (magnification 10). (F) The cells cultured in control medium
remained von Kossa negative (magnification 10). (G) von Kossa staining revealed calcified extracellular matrix (black) in muADAS
cells cultured for 4 weeks in osteogenic medium (magnification 10). (H) The cells maintained in control medium remained von Kossa
negative (magnification 10). (Color images available online at www.liebertpub.com/ten.)
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irradiated SJL/J recipient mice. The intravenous injection of
1 106 muADAS cells per mouse (n ¼ 4 mice) induced
immediate mouse death, a result that parallels findings re-
ported by other researchers.11 After intraperitoneal trans-
plantation of muADAS cells into 4 lethally irradiated SJL/J
mice, the treated mice and control mice died within 3 weeks
of transplantation. We also investigated the effect of in-
travenous injection (into the tail vein) of fewer cells (1 105
and 5 105) into lethally irradiated mice (n ¼ 8 mice, 4 per
quantity of cells). The mice did not immediately die, which
indicates that injection of the decreased quantities of cells
did not cause fat boluses in these mice. However, the treated
mice and control mice died within 3 weeks of transplanta-
tion. This finding demonstrates that the muADAS cells
failed to reconstitute the bone marrow and hence failed to
provide radiation protection to treated mice.
DISCUSSION
The results of this study demonstrate that a population of
cells isolated from the visceral fat of mice can undergo
FIG. 3. (A) Murine adipose-derived adult stem (muADAS) cells were transduced with a retrovirus containing the LacZ gene and were
identifiable by their LacZ-expressing nuclei after b-galactosidase staining (magnification 20). (B) Radiographic examination showed
intramuscular bone formation in SCID mice 28 days after implantation of muADAS cells cotransduced to express LacZ and BMP4.
(C) In vivo chondrogenesis by muADAS cells was determined by colocalization of round chondrocytes with blue nuclei (arrow) after
staining for LacZ/eosin (magnification 60) and (D) by positive immunostaining for LacZ/collagen type II (brown) (magnification 60).
(E) In vivo osteogenesis by muADAS cells was confirmed by colocalization of blue cells in the newly formed bone tissue (arrow,
magnification 60) (F) with osteocalcin (brown) (arrow, magnification 60).
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multilineage differentiation in vitro and in vivo. This
muADAS cell population contains fibroblast-like cells that
are easy to expand in vitro without specific serum supple-
mentation. The muADAS cells used in our study differ-
entiated toward the adipogenic, osteogenic, chondrogenic,
and myogenic lineages when cultured in the presence of
established lineage-specific differentiation factors. The
ability of muADAS cells to undergo multilineage differ-
entiation suggests that a stem cell population exists within
mouse adipose tissue. The observed multilineage differ-
entiation may also be attributed to the presence of multiple
populations of lineage-committed progenitor cells within
adipose tissue (e.g., pre-osteoblasts, pre-myoblasts, or pre-
adipocytes), multipotent cells from other sources (e.g., blood
vessels or pericytes), or a combination of these populations.
muADAS cell populations obtained from excised adipose
tissue are known to contain pre-adipocytes that differenti-
ate into mature adipocytes. The adipogenic differentiation
FIG. 4. Ectopic bone formation 24 weeks after implantation of muADAS-LacZ-BMP cells into muscle pockets of SCID mice.
(A) Radiographic examination. (B) The histology of ectopic bone tissue (arrows, 20). (C) In vivo ectopic bone tissue included some
areas of cartilage, as shown by Alcian blue staining (magnification 40). (D) Chondrogenesis of murine adipose-derived adult stem
(muADAS) cells was shown by positive immunostaining for colocalization of collagen type II (red)/b-galactosidase (green) (arrow,
magnification 40). In vivo osteogenesis by muADAS cells was confirmed (E) by LacZ/eosin (magnification 60) and (F) by positive
immunostaining for colocalization of osteocalcin (red)/b-gal (green) (arrow, magnification 60).
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exhibited by the muADAS cells also could be due to the
commitment of existing pre-adipocytes rather than to the
differentiation of multipotent cells. However, such an ex-
planation is unconvincing in the case of humans, because as
few as 0.02% of the SVF cells in adipose tissue excised
from humans are pre-adipocytes that can undergo adipo-
genic differentiation.6 Therefore, the large-scale adipo-
genesis observed in our study more likely resulted from the
differentiation of muADAS cells themselves.
Our observations of muADAS cells under control con-
ditions also revealed changes in their expression of CD34
and Sca-1, both of which are progenitor cell surface mar-
kers. Our analysis of muADAS cells at 10 passages in-
dicated that 74.94% expressed Sca-1 and 3.25% expressed
CD34. In comparison, the expression of Sca-1 and CD34 by
muADAS cells at 4 passages was 31% and 10%, respec-
tively. We are investigating whether these changes in the
marker expression profile reflect the different proliferation
rates of stem cells and differentiated cells. Because we iso-
lated the cells from visceral fat, the involvement of myo-
genic precursor cells or satellite cells in the observed
myogenic differentiation is unlikely. Furthermore, the
freshly isolated muADAS cells did not express the myo-
genic marker desmin. Desmin was only expressed when
muADAS cells were cultured in myogenic medium. This
finding suggests that the myogenic differentiation observed
in this study was not due to the activity of myogenic pre-
cursors or proliferating myoblasts within the muADAS cell
population.
The circulatory system, which contains potentially mul-
tipotent cells such as pericytes and marrow-derived me-
senchymal stem cells, is another possible source of stem cell
contamination of the muADAS cell population. Disruption
of the blood supply during isolation could have resulted in
the release of hematopoietic progenitors, which are known
to give rise to hematopoietic lineages in vivo and in vitro; 11
however, flow cytometry revealed no CD45-positive cells in
the muADAS cell population. In addition, prior research
revealed no hematopoietic cells in muADAS cell cultures at
2 to 3 passages.9,20 Although our in vitro data suggest that
the muADAS cells might have at least limited hemato-
poietic potential, muADAS cells transplanted intravenously
or intraperitoneally failed to prevent the death of lethally
irradiated SJL/J mice. The immediate death of the mice
after intravenous injection of muADAS cells could be due
to the formation of a fat bolus in critical organs such as
the brain or heart. The inability of intraperitoneally and
intravenously injected muADAS cells to reconstitute the
hosts’ bone marrow suggests that the in vivo hematopoietic
potential of these cells is, at best, limited. Because of these
findings, definitive confirmation of the existence of multi-
potent stem cells within adipose tissue will require the
isolation and characterization of multiple clones.
Researchers have demonstrated that bone marrow–
derived mesenchymal stem cells can differentiate toward
osteogenic and chondrogenic lineages in vivo, and pre-
liminary data suggest that these cells can facilitate the re-
pair of bone and cartilage defects.21–24 However, harvesting
bone marrow is an invasive procedure, and the marrow
contains only a limited number of progenitor cells. Many
studies of ADAS cells have focused on the cells’ ability to
differentiate toward various lineages in vitro or their po-
tential to repair bone and cartilage in vivo; few studies have
investigated the long-term fate of donor ADAS cells in-
fluenced by BMP4 in vivo. The results presented here de-
monstrate that ADAS cells transduced with a retrovirus
containing LacZ and BMP4 genes and implanted into the
skeletal muscle of mice differentiated toward the chon-
drogenic and osteogenic lineages and continued to survive
within ectopic bone tissue 6 months after implantation.
Moreover, radiographic analysis revealed that the ectopic
bone formed in vivo maintained its size for 5 months (from
4 to 24 weeks after implantation, Figs. 3B, 4A). Histologic
analysis also revealed a greater amount of dense bone and
cartilage in the samples obtained 24 weeks after im-
plantation than in those harvested 4 weeks after implanta-
tion. These observations indicate that the ectopic cartilage
and bone tissue formed by the transduced muADAS cells
was stable and persistent, which suggests that ADAS cells
could serve as a good cell source for bone and cartilage
regeneration.
In conclusion, these observations validate the notion
that muADAS cells could serve as a cell source for gene
FIG. 5. (A) Murine adipose-derived adult stem (muADAS) cells
cultured for 6 weeks in myogenic medium expressed desmin (red,
magnification 20). Hoechst staining (blue) revealed the cell nu-
clei. (B) Few muADAS cells participated in muscle regeneration,
as determined by the number of LacZ-positive myofibers in the
mdx mouse muscle 15 days after injection (magnification 20,
bottom left-hand corner insets, 60). (C) Large colonies com-
posed of small cells were found in methylcellulose cultures of
muADAS cells (magnification, 5). (D) After picking, cytospin-
ning, and staining the colonies with Wright-Giemsa stain, we
observed granulomonocytic cells (magnification 100).
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therapy. The limited ability of those cells to undergo
myogenic and hematopoietic differentiation restricted their
utility for muscle regeneration and reconstitution of bone
marrow. On the other hand, their high capacity for bone and
cartilage repair and their long-term survival under the in-
fluence of BMP4 in vivo suggest that they might be a useful
cell source for osteogenic and chondrogenic applications.
The origin of these multipotent cells isolated from adi-
pose tissue remains unclear and will be the focus of future
research.
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